# | Title | Journal | Year | Citations |
---|
|
1 | Model-based Analysis of ChIP-Seq (MACS) | Genome Biology | 2008 | 14,393 |
2 | EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy | Science | 2004 | 9,112 |
3 | Computational Radiomics System to Decode the Radiographic Phenotype | Cancer Research | 2017 | 3,880 |
4 | Malignant Gliomas in Adults | New England Journal of Medicine | 2008 | 3,736 |
5 | Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq | Science | 2016 | 3,690 |
6 | Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach | Nature Communications | 2014 | 3,501 |
7 | Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group | Journal of Clinical Oncology | 2010 | 3,320 |
8 | Integrative Clinical Genomics of Advanced Prostate Cancer | Cell | 2015 | 2,809 |
9 | Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNA | Cell Stem Cell | 2010 | 2,412 |
10 | Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses | Proceedings of the National Academy of Sciences of the United States of America | 2001 | 2,297 |
11 | An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors | Nature Genetics | 2008 | 2,255 |
12 | Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma | Journal of Clinical Oncology | 2009 | 2,249 |
13 | Nanoparticles in Medicine: Therapeutic Applications and Developments | Clinical Pharmacology and Therapeutics | 2008 | 2,198 |
14 | PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors | Science | 2003 | 2,176 |
15 | Gene expression correlates of clinical prostate cancer behavior | Cancer Cell | 2002 | 2,171 |
16 | Epigenetic memory in induced pluripotent stem cells | Nature | 2010 | 2,038 |
17 | Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer | Cell | 2017 | 1,827 |
18 | Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK | Journal of Clinical Oncology | 2009 | 1,792 |
19 | Hepatocellular carcinoma pathogenesis: from genes to environment | Nature Reviews Cancer | 2006 | 1,774 |
20 | The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP | Proceedings of the National Academy of Sciences of the United States of America | 2008 | 1,743 |
21 | Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription | Cell | 2000 | 1,578 |
22 | Relative Impact of Nucleotide and Copy Number Variation on Gene Expression Phenotypes | Science | 2007 | 1,559 |
23 | Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes | Blood | 2015 | 1,556 |
24 | EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells | Proceedings of the National Academy of Sciences of the United States of America | 2003 | 1,495 |
25 | Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib | Journal of Clinical Oncology | 2005 | 1,409 |
26 | Functional genomics reveal that the serine synthesis pathway is essential in breast cancer | Nature | 2011 | 1,400 |
27 | Prolonged Grief Disorder: Psychometric Validation of Criteria Proposed for DSM-V and ICD-11 | PLoS Medicine | 2009 | 1,366 |
28 | Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men | Journal of Urology | 1994 | 1,354 |
29 | Selective Blockade of MicroRNA Processing by Lin28 | Science | 2008 | 1,331 |
30 | Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy for Prostate Cancer | Journal of Clinical Oncology | 2006 | 1,324 |
31 | Combining immunotherapy and targeted therapies in cancer treatment | Nature Reviews Cancer | 2012 | 1,305 |
32 | Chemokines and disease | Nature Immunology | 2001 | 1,297 |
33 | Cytokines in cancer pathogenesis and cancer therapy | Nature Reviews Cancer | 2004 | 1,283 |
34 | Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781 | Journal of Clinical Oncology | 2008 | 1,264 |
35 | Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours | Journal of Pathology | 2014 | 1,187 |
36 | Declining NAD+ Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication during Aging | Cell | 2013 | 1,177 |
37 | Oxygen sensing and molecular adaptation to hypoxia | Physiological Reviews | 1996 | 1,135 |
38 | Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma | New England Journal of Medicine | 2021 | 1,103 |
39 | Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages | Blood | 2016 | 1,102 |
40 | Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors | Cancer Discovery | 2013 | 1,101 |
41 | Communication About Serious Illness Care Goals | JAMA Internal Medicine | 2014 | 1,089 |
42 | Biology of Gastrointestinal Stromal Tumors | Journal of Clinical Oncology | 2004 | 1,080 |
43 | Activation of Hypoxia-inducible Transcription Factor Depends Primarily upon Redox-sensitive Stabilization of Its α Subunit | Journal of Biological Chemistry | 1996 | 1,076 |
44 | Molecular Determinants for the Tissue Specificity of SERMs | Science | 2002 | 1,076 |
45 | Tumor heterogeneity: Causes and consequences | Biochimica Et Biophysica Acta: Reviews on Cancer | 2010 | 1,074 |
46 | Artificial intelligence in cancer imaging: Clinical challenges and applications | Ca-A Cancer Journal for Clinicians | 2019 | 1,073 |
47 | Myocarditis in Patients Treated With Immune Checkpoint Inhibitors | Journal of the American College of Cardiology | 2018 | 1,066 |
48 | Recurrent BRAF mutations in Langerhans cell histiocytosis | Blood | 2010 | 1,038 |
49 | Epidemiology of Brain Metastases | Current Oncology Reports | 2012 | 1,035 |
50 | Epidemiology of Renal Cell Carcinoma | European Urology | 2019 | 1,009 |